← Leaderboards
Carla Yunis
Wake Forest University
$0
Attributed
$0
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 2
By mechanism
M01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Wake Forest University
Same institution · by research overlap
- Carlos M Ferrario$10,416,810
- Mark C Chappell$5,789,698
- Kathleen Bridget Brosnihan$6,775,445
- Elisabeth Ann Tallant$3,392,401
- James C Eisenach$18,874,166
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationHypertensionClinical ResearchDietary SodiumHuman SubjectGenetic MarkersGenetic SusceptibilityHormone TherapyLisinoprilProtease InhibitorAngiotensin /Renin /Aldosterone HypertensionSaluresisAngiotensinsAntihypertensive AgentsClinical Trial Phase IDrug Screening /Evaluation
Grant awards (4)
METALLOPROTEASE INHIBITOR OMAPATRIALAT &LISINOPRIL IN H$0
M01 · FY2002 · RR
GENETIC MARKERS FOR SALT-SENSITIVITY &ANGIOTENSIN PEPTIDES IN HYPERTENSION$0
M01 · FY2002 · RR
METALLOPROTEASE INHIBITOR OMAPATRIALAT &LISINOPRIL IN H$0
M01 · FY2000 · RR
GENETIC MARKERS FOR SALT-SENSITIVITY &ANGIOTENSIN PEPTIDES IN HYPERTENSION$0
M01 · FY2000 · RR